SAGE THERAPEUTICS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at SAGE THERAPEUTICS is $150,000, based on 43 certified filings from FY 2020 to FY 2025. This is 25% higher than the national H-1B median salary of $120,000. Compensation at SAGE THERAPEUTICS reflects their market positioning, with entry-level roles starting around $138,000 and senior positions reaching $190,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at SAGE THERAPEUTICS range from $124,999 at the 10th percentile to $190,000 at the 90th percentile, showing a $65,001 spread across experience levels and roles. The 25th percentile is $138,000 and the 75th percentile is $185,000.

Yes, SAGE THERAPEUTICS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 45 H-1B labor condition applications from FY 2020 to FY 2025, demonstrating ongoing commitment to hiring international talent. With 43 certified applications and a 2.2% denial rate, SAGE THERAPEUTICS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), SAGE THERAPEUTICS filed 2 H-1B applications, with 2 certified and 0 denied. Over 6 years of data, SAGE THERAPEUTICS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

SAGE THERAPEUTICS's LCA (Labor Condition Application) denial rate is 2.2%, with 1 out of 45 applications denied across all years. This translates to a 97.8% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating SAGE THERAPEUTICS as a potential H-1B sponsor.

This denial rate is higher than average. Applicants should ensure all documentation is thoroughly prepared and work closely with SAGE THERAPEUTICS's immigration team.

SAGE THERAPEUTICS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 43 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles SAGE THERAPEUTICS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at SAGE THERAPEUTICS:

The most frequently sponsored role is Senior Research Scientist with 2 filings at a median salary of $150,000. This is followed by Associate Director, Cmc Regulatory Affairs (2 filings) and Senior Manager, Dspv Quality, Compliance & Training.

SAGE THERAPEUTICS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where SAGE THERAPEUTICS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top SAGE THERAPEUTICS H-1B locations:

The largest H-1B hub for SAGE THERAPEUTICS is Cambridge, MA with 21 filings at a median salary of $139,931. The highest-paying location is Shrewsbury, MA at $204,750 median. Salaries range from $130,000 to $204,750 across office locations.

SAGE THERAPEUTICS's median H-1B salary has increased by +29% from FY 2020 ($147,659) to FY 2025 ($190,000). Tracking salary trends over time reveals how SAGE THERAPEUTICS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at SAGE THERAPEUTICS.

Year-by-year breakdown:

• FY 2021: $139,931 (16 certified)
• FY 2022: $150,000 (6 certified)
• FY 2023: $160,000 (6 certified)
• FY 2024: $185,000 (9 certified)
• FY 2025: $190,000 (2 certified)

This 29% growth reflects strong compensation adjustments at SAGE THERAPEUTICS, keeping pace with market demands for H-1B talent.

SAGE THERAPEUTICS primarily files H-1B applications at Wage Level IV, accounting for 64% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making SAGE THERAPEUTICS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 100% of positions at Level II or higher, SAGE THERAPEUTICS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

SAGE THERAPEUTICS's median H-1B salary of $150,000 is 25% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating SAGE THERAPEUTICS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare SAGE THERAPEUTICS's offerings with similar companies in your field for a more accurate assessment.

This places SAGE THERAPEUTICS among the higher-paying H-1B sponsors in the industry. Candidates considering H-1B sponsorship should weigh this competitive compensation alongside other factors like role growth, location, and visa processing track record.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. SAGE THERAPEUTICS's higher proportion of Level III-IV positions (81%) may benefit from wage-based lottery prioritization.

With 43 certified filings, SAGE THERAPEUTICS invests significantly in H-1B sponsorship. The company's 2.2% denial rate suggests solid H-1B processing practices.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.